MedPath
NMPA Approval

Regorafenib Tablets

国药准字H20253676

March 25, 2025

Drug Information

瑞戈非尼片

片剂

40mg

化学药品

March 25, 2025

Company Information

Applicant Company

北京市海淀区阜石路69号碧桐园1号楼4层

Manufacturing Company

北京市大兴区中关村科技园区大兴生物医药产业基地华佗路32号院

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞戈非尼片 - NMPA 批准文号 | MedPath